3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia

• Status: Unknown status
• Trial end date: 2015-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The goal: to evaluate the role of high dose ara-c plus idarubicin and mitoxantrone consolidation followed by maintenance in the setting of high total cumulative anthracyclines dose(720-660 mg/m2).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Research Center for Hematology, Russia
• Treatments: Cytarabine; Daunorubicin; Idarubicin; Mitoxantrone

Criteria

Inclusion Criteria:

• de novo acute myeloid leukemia - age 15-60

Exclusion Criteria:

• secondary acute myeloid leukemia

• acute myeloid leukemia from myelodysplastic syndrome

• Ph+ acute myeloid leukemia